Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia

NCT06931938
completed

Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning

NCT05060926
completednot_applicable

Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure

NCT04477655
completednot_applicable

COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss

NCT04395144

Clinical Trials (4)

Showing 4 of 4 trials
NCT06931938Not Applicable

Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia

Recruiting
NCT05060926

Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning

Completed
NCT04477655Not Applicable

Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure

Completed
NCT04395144Not Applicable

COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4